Global Myasthenia Gravis Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Myasthenia Gravis market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Myasthenia Gravis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myasthenia Gravis development in United States, Europe and China.
    
    The key players covered in this study
        Shire
        F. Hoffmann-La Roche
        CSL Behring
        Grifols
        Alexion Pharmaceutical
        Avadel Pharmaceuticals
        Baxter International
        Novartis
        Valeant Pharmaceuticals International
        Takeda Pharmaceutical Company
    
    Market segment by Type, the product can be split into
        Drug Treatment
        Rapid Immunotherapies
    
    Market segment by Application, split into
        Hospitals
        Clinics
        Other
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Myasthenia Gravis status, future forecast, growth opportunity, key market and key players.
        To present the Myasthenia Gravis development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Myasthenia Gravis are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Myasthenia Gravis Market Size Growth Rate by Type (2013-2025)
            1.4.2 Drug Treatment
            1.4.3 Rapid Immunotherapies
        1.5 Market by Application
            1.5.1 Global Myasthenia Gravis Market Share by Application (2013-2025)
            1.5.2 Hospitals
            1.5.3 Clinics
            1.5.4 Other
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Myasthenia Gravis Market Size
        2.2 Myasthenia Gravis Growth Trends by Regions
            2.2.1 Myasthenia Gravis Market Size by Regions (2013-2025)
            2.2.2 Myasthenia Gravis Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Myasthenia Gravis Market Size by Manufacturers
            3.1.1 Global Myasthenia Gravis Revenue by Manufacturers (2013-2018)
            3.1.2 Global Myasthenia Gravis Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
        3.2 Myasthenia Gravis Key Players Head office and Area Served
        3.3 Key Players Myasthenia Gravis Product/Solution/Service
        3.4 Date of Enter into Myasthenia Gravis Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Myasthenia Gravis Market Size by Type (2013-2018)
        4.2 Global Myasthenia Gravis Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Myasthenia Gravis Market Size (2013-2018)
        5.2 Myasthenia Gravis Key Players in United States
        5.3 United States Myasthenia Gravis Market Size by Type
        5.4 United States Myasthenia Gravis Market Size by Application
    
    6 Europe
        6.1 Europe Myasthenia Gravis Market Size (2013-2018)
        6.2 Myasthenia Gravis Key Players in Europe
        6.3 Europe Myasthenia Gravis Market Size by Type
        6.4 Europe Myasthenia Gravis Market Size by Application
    
    7 China
        7.1 China Myasthenia Gravis Market Size (2013-2018)
        7.2 Myasthenia Gravis Key Players in China
        7.3 China Myasthenia Gravis Market Size by Type
        7.4 China Myasthenia Gravis Market Size by Application
    
    8 Japan
        8.1 Japan Myasthenia Gravis Market Size (2013-2018)
        8.2 Myasthenia Gravis Key Players in Japan
        8.3 Japan Myasthenia Gravis Market Size by Type
        8.4 Japan Myasthenia Gravis Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Myasthenia Gravis Market Size (2013-2018)
        9.2 Myasthenia Gravis Key Players in Southeast Asia
        9.3 Southeast Asia Myasthenia Gravis Market Size by Type
        9.4 Southeast Asia Myasthenia Gravis Market Size by Application
    
    10 India
        10.1 India Myasthenia Gravis Market Size (2013-2018)
        10.2 Myasthenia Gravis Key Players in India
        10.3 India Myasthenia Gravis Market Size by Type
        10.4 India Myasthenia Gravis Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Myasthenia Gravis Market Size (2013-2018)
        11.2 Myasthenia Gravis Key Players in Central & South America
        11.3 Central & South America Myasthenia Gravis Market Size by Type
        11.4 Central & South America Myasthenia Gravis Market Size by Application
    
    12 International Players Profiles
        12.1 Shire
            12.1.1 Shire Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Myasthenia Gravis Introduction
            12.1.4 Shire Revenue in Myasthenia Gravis Business (2013-2018)
            12.1.5 Shire Recent Development
        12.2 F. Hoffmann-La Roche
            12.2.1 F. Hoffmann-La Roche Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Myasthenia Gravis Introduction
            12.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2013-2018)
            12.2.5 F. Hoffmann-La Roche Recent Development
        12.3 CSL Behring
            12.3.1 CSL Behring Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Myasthenia Gravis Introduction
            12.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2013-2018)
            12.3.5 CSL Behring Recent Development
        12.4 Grifols
            12.4.1 Grifols Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Myasthenia Gravis Introduction
            12.4.4 Grifols Revenue in Myasthenia Gravis Business (2013-2018)
            12.4.5 Grifols Recent Development
        12.5 Alexion Pharmaceutical
            12.5.1 Alexion Pharmaceutical Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Myasthenia Gravis Introduction
            12.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2013-2018)
            12.5.5 Alexion Pharmaceutical Recent Development
        12.6 Avadel Pharmaceuticals
            12.6.1 Avadel Pharmaceuticals Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Myasthenia Gravis Introduction
            12.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2013-2018)
            12.6.5 Avadel Pharmaceuticals Recent Development
        12.7 Baxter International
            12.7.1 Baxter International Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Myasthenia Gravis Introduction
            12.7.4 Baxter International Revenue in Myasthenia Gravis Business (2013-2018)
            12.7.5 Baxter International Recent Development
        12.8 Novartis
            12.8.1 Novartis Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Myasthenia Gravis Introduction
            12.8.4 Novartis Revenue in Myasthenia Gravis Business (2013-2018)
            12.8.5 Novartis Recent Development
        12.9 Valeant Pharmaceuticals International
            12.9.1 Valeant Pharmaceuticals International Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Myasthenia Gravis Introduction
            12.9.4 Valeant Pharmaceuticals International Revenue in Myasthenia Gravis Business (2013-2018)
            12.9.5 Valeant Pharmaceuticals International Recent Development
        12.10 Takeda Pharmaceutical Company
            12.10.1 Takeda Pharmaceutical Company Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Myasthenia Gravis Introduction
            12.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2013-2018)
            12.10.5 Takeda Pharmaceutical Company Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Myasthenia Gravis Key Market Segments
        Table Key Players Myasthenia Gravis Covered
        Table Global Myasthenia Gravis Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Myasthenia Gravis Market Size Market Share by Type 2013-2025
        Figure Drug Treatment Figures
        Table Key Players of Drug Treatment
        Figure Rapid Immunotherapies Figures
        Table Key Players of Rapid Immunotherapies
        Table Global Myasthenia Gravis Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospitals Case Studies
        Figure Clinics Case Studies
        Figure Other Case Studies
        Figure Myasthenia Gravis Report Years Considered
        Table Global Myasthenia Gravis Market Size 2013-2025 (Million US$)
        Figure Global Myasthenia Gravis Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Myasthenia Gravis Market Size by Regions 2013-2025 (Million US$)
        Table Global Myasthenia Gravis Market Size by Regions 2013-2018 (Million US$)
        Table Global Myasthenia Gravis Market Share by Regions 2013-2018
        Figure Global Myasthenia Gravis Market Share by Regions 2013-2018
        Figure Global Myasthenia Gravis Market Share by Regions 2018
        Table Market Top Trends
        Table Global Myasthenia Gravis Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Myasthenia Gravis Market Share by Manufacturers (2013-2018)
        Figure Global Myasthenia Gravis Market Share by Manufacturers in 2018
        Table Global Myasthenia Gravis Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Myasthenia Gravis Product/Solution/Service
        Table Date of Enter into Myasthenia Gravis Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table Global Myasthenia Gravis Market Size Share by Type (2013-2018)
        Figure Global Myasthenia Gravis Market Size Market Share by Type (2013-2018)
        Table Global Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table Global Myasthenia Gravis Market Size Share by Application (2013-2018)
        Figure Global Myasthenia Gravis Market Size Market Share by Application (2013-2018)
        Figure Global Myasthenia Gravis Revenue Market Share by Application in 2017
        Figure United States Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table United States Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table United States Key Players Myasthenia Gravis Market Share (2017-2018)
        Table United States Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table United States Myasthenia Gravis Market Share by Type (2013-2018)
        Table United States Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table United States Myasthenia Gravis Market Share by Application (2013-2018)
        Figure Europe Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table Europe Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table Europe Key Players Myasthenia Gravis Market Share (2017-2018)
        Table Europe Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table Europe Myasthenia Gravis Market Share by Type (2013-2018)
        Table Europe Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table Europe Myasthenia Gravis Market Share by Application (2013-2018)
        Figure China Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table China Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table China Key Players Myasthenia Gravis Market Share (2017-2018)
        Table China Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table China Myasthenia Gravis Market Share by Type (2013-2018)
        Table China Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table China Myasthenia Gravis Market Share by Application (2013-2018)
        Figure Japan Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table Japan Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table Japan Key Players Myasthenia Gravis Market Share (2017-2018)
        Table Japan Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table Japan Myasthenia Gravis Market Share by Type (2013-2018)
        Table Japan Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table Japan Myasthenia Gravis Market Share by Application (2013-2018)
        Figure Southeast Asia Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Myasthenia Gravis Market Share (2017-2018)
        Table Southeast Asia Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Myasthenia Gravis Market Share by Type (2013-2018)
        Table Southeast Asia Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Myasthenia Gravis Market Share by Application (2013-2018)
        Figure India Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table India Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table India Key Players Myasthenia Gravis Market Share (2017-2018)
        Table India Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table India Myasthenia Gravis Market Share by Type (2013-2018)
        Table India Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table India Myasthenia Gravis Market Share by Application (2013-2018)
        Figure Central & South America Myasthenia Gravis Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Myasthenia Gravis Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Myasthenia Gravis Market Share (2017-2018)
        Table Central & South America Myasthenia Gravis Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Myasthenia Gravis Market Share by Type (2013-2018)
        Table Central & South America Myasthenia Gravis Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Myasthenia Gravis Market Share by Application (2013-2018)
        Table Shire Company Details
        Table Shire Revenue in Myasthenia Gravis Business (2013-2018) (Million US$)
        Figure Shire Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Shire Recent Development
        Table F. Hoffmann-La Roche Company Details
        Table F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table F. Hoffmann-La Roche Recent Development
        Table CSL Behring Company Details
        Table CSL Behring Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table CSL Behring Recent Development
        Table Grifols Company Details
        Table Grifols Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Grifols Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Grifols Recent Development
        Table Alexion Pharmaceutical Company Details
        Table Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Alexion Pharmaceutical Recent Development
        Table Avadel Pharmaceuticals Company Details
        Table Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Avadel Pharmaceuticals Recent Development
        Table Baxter International Company Details
        Table Baxter International Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Baxter International Recent Development
        Table Novartis Company Details
        Table Novartis Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Novartis Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Novartis Recent Development
        Table Valeant Pharmaceuticals International Company Details
        Table Valeant Pharmaceuticals International Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Valeant Pharmaceuticals International Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Valeant Pharmaceuticals International Recent Development
        Table Takeda Pharmaceutical Company Company Details
        Table Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2013-2018)(Million US$)
        Figure Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2013-2018)
        Table Takeda Pharmaceutical Company Recent Development
        Table Global Myasthenia Gravis Market Size by Regions (Million US$) 2018-2025
        Figure Global Myasthenia Gravis Market Size Share by Regions (2018-2025)
        Figure Global Myasthenia Gravis Market Size Share by Regions in 2025
        Figure United States Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure China Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure India Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Myasthenia Gravis Market Size Forecast (2018-2025)(Million USD)
        Table Global Myasthenia Gravis Market Size by Product (2018-2025) (Million US$)
        Figure Global Myasthenia Gravis Market Size by Product (2018-2025)
        Figure Global Myasthenia Gravis Market Size by Product in 2025
        Table Global Myasthenia Gravis Market Size by Application (2018-2025) (Million US$)
        Figure Global Myasthenia Gravis Market Size by Application (2018-2025)
        Figure Global Myasthenia Gravis Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources